Terms: = Breast cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223
213 results:
1. Label-free nonlinear optical signatures of extracellular vesicles in liquid and tissue biopsies of human breast cancer.
Sorrells JE; Park J; Aksamitiene E; Marjanovic M; Martin EM; Chaney EJ; Higham AM; Cradock KA; Liu ZG; Boppart SA
Sci Rep; 2024 Mar; 14(1):5528. PubMed ID: 38448508
[TBL] [Abstract] [Full Text] [Related]
2. Multispectral Imaging of Metabolic Fluorophores: Comparing In Vivo and Fresh Ex Vivo Tissue.
Carver GE; Locknar SA; Ghule PN; Pung CJ; Weaver DL; Stein JL; Stein GS
Crit Rev Eukaryot Gene Expr; 2024; 34(1):69-74. PubMed ID: 37824393
[TBL] [Abstract] [Full Text] [Related]
3. Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells.
Kopecka J; Barbanente A; Vitone D; Arnesano F; Margiotta N; Berchialla P; Niso M; Riganti C; Abate C
Pharmacol Rep; 2023 Dec; 75(6):1588-1596. PubMed ID: 37796435
[TBL] [Abstract] [Full Text] [Related]
4. FBXL12 degrades fancd2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress.
Brunner A; Li Q; Fisicaro S; Kourtesakis A; Viiliäinen J; Johansson HJ; Pandey V; Mayank AK; Lehtiö J; Wohlschlegel JA; Spruck C; Rantala JK; Orre LM; Sangfelt O
Mol Cell; 2023 Oct; 83(20):3720-3739.e8. PubMed ID: 37591242
[TBL] [Abstract] [Full Text] [Related]
5. breast tissue analysis using a clinically compatible combined time-resolved fluorescence and diffuse reflectance (TRF-DR) system.
Dao E; Gohla G; Williams P; Lovrics P; Badr F; Fang Q; Farrell T; Farquharson M
Lasers Surg Med; 2023 Oct; 55(8):769-783. PubMed ID: 37526280
[TBL] [Abstract] [Full Text] [Related]
6. Stage Analysis of breast cancer Metabolomics: A System Biology Approach.
Hosseinpour Z; Rezaei Tavirani M; Akbari ME
Asian Pac J Cancer Prev; 2023 May; 24(5):1571-1582. PubMed ID: 37247276
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract] [Full Text] [Related]
8. Association of Reported Candidate Monogenic Genes With Lung cancer Risk.
Rifkin AS; Less EM; Wei J; Shi Z; Zheng SL; Helfand BT; Hulick PJ; Krantz SB; Xu J
Clin Lung Cancer; 2023 Jun; 24(4):313-321. PubMed ID: 36781323
[TBL] [Abstract] [Full Text] [Related]
9. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.
Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA
Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691
[TBL] [Abstract] [Full Text] [Related]
10. Partial Reduction in
Classen S; Rahlf E; Jungwirth J; Albers N; Hebestreit LP; Zielinski A; Poole L; Groth M; Koch P; Liehr T; Kankel S; Cordes N; Petersen C; Rothkamm K; Pospiech H; Borgmann K
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362151
[No Abstract] [Full Text] [Related]
11. Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer.
Yang M; Mahanty A; Jin C; Wong ANN; Yoo JS
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096527
[TBL] [Abstract] [Full Text] [Related]
12. Human fibroblasts facilitate the generation of iPSCs-derived mammary-like organoids.
Dai X; Wang X; Yang C; Huang M; Zhou Z; Qu Y; Cui X; Liu R; Chen C
Stem Cell Res Ther; 2022 Jul; 13(1):377. PubMed ID: 35902878
[TBL] [Abstract] [Full Text] [Related]
13. SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.
Lu Z; Mao W; Yang H; Santiago-O'Farrill JM; Rask PJ; Mondal J; Chen H; Ivan C; Liu X; Liu CG; Xi Y; Masuda K; Carrami EM; Chen M; Tang Y; Pang L; Lakomy DS; Calin GA; Liang H; Ahmed AA; Vankayalapati H; Bast RC
J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35642638
[TBL] [Abstract] [Full Text] [Related]
14. Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National cancer Registry Program.
Kulothungan V; Sathishkumar K; Leburu S; Ramamoorthy T; Stephen S; Basavarajappa D; Tomy N; Mohan R; Menon GR; Mathur P
BMC Cancer; 2022 May; 22(1):527. PubMed ID: 35546232
[TBL] [Abstract] [Full Text] [Related]
15. Ferroptosis-based molecular prognostic model for adrenocortical carcinoma based on least absolute shrinkage and selection operator regression.
Lin C; Hu R; Sun F; Liang W
J Clin Lab Anal; 2022 Jun; 36(6):e24465. PubMed ID: 35500219
[TBL] [Abstract] [Full Text] [Related]
16. Folic Acid-Functionalized Carbon Dot-Enabled Starvation Therapy in Synergism with Paclitaxel against breast cancer.
Ghosh A; Ghosh AK; Chowdhury M; Das PK
ACS Appl Bio Mater; 2022 May; 5(5):2389-2402. PubMed ID: 35452214
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of conformational transitions of h-BRCA2 functional domain and unclassified variant Arg2502Cys using multimodal approach.
Khan MA; Siddiqui MQ; Kuligina E; Varma AK
Int J Biol Macromol; 2022 Jun; 209(Pt A):716-724. PubMed ID: 35413318
[TBL] [Abstract] [Full Text] [Related]
18. Comparative Proteomic Profiling of Secreted Extracellular Vesicles from breast Fibroadenoma and Malignant Lesions: A Pilot Study.
Pane K; Quintavalle C; Nuzzo S; Ingenito F; Roscigno G; Affinito A; Scognamiglio I; Pattanayak B; Gallo E; Accardo A; Thomas G; Minic Z; Berezovski MV; Franzese M; Condorelli G
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409352
[TBL] [Abstract] [Full Text] [Related]
19. Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway.
Preethi S; Arthiga K; Patil AB; Spandana A; Jain V
Mol Biol Rep; 2022 Sep; 49(9):8907-8924. PubMed ID: 35347544
[TBL] [Abstract] [Full Text] [Related]
20. Flavin Adenine Dinucleotide (fad) Pegylated (PEG)-Complexes: Proof of Concept (PoC) of theranostic tool on a Murine breast cancer Model.
Arib C; Liu H; Liu Q; Cieutat AM; Paleni D; Li X; Spadavecchia J
Nanotheranostics; 2022; 6(2):175-183. PubMed ID: 34976592
[TBL] [Abstract] [Full Text] [Related]
[Next]
